Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature

References

• SchindlerAENon-contraceptive benefits of oral hormonal contraceptivesInt J Endocrinol Metab2013111414723853619
   PubMedGoogle Scholar
• YAZ^® (drospirenone/ethinyl estradiol) tablets for oral use [prescribing information]Monteville, NJBayer HealthCare Pharmaceuticals, Inc2012
   Google Scholar
• Dianette^® [summary of product characteristics]BerlinBayer Pharma AG2013
   Google Scholar
• Ortho Tri-Cyclen^® tablets (norgestimate/ethinyl estradiol) tablets [prescribing information]Titusville, NJJanssen Pharmaceuticals, Inc2013
   Google Scholar
• ESTROSTEP^® Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) tablets [prescribing information]Rockaway, NJWarner Chilcott Company LLC2009
   Google Scholar
• BayerScheringPharmaAGDiane-35Berlin-WeddingBayer Schering Pharma AG2010 Available from: http://www.pharmaline.co.il/images/newsletterregistration/bayer/11022011/dianedr.pdfAccessed March 20, 2014
   Google Scholar
• NATAZIA^® (estradiol valerate and estradiol valerate/dienogest) tablets, for oral use [prescribing information]Monteville, NJBayer Health Care Pharmaceuticals, Inc2013
   Google Scholar
• VeljkovićMVeljkovićSThe risk of breast cervical, endometrial and ovarian cancer in oral contraceptive usersMed Pregl2010639–10657661 Serbian21446095
   PubMedGoogle Scholar
• DossusLAllenNKaaksRReproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and NutritionInt J Cancer2010127244245119924816
   PubMed Web of Science ®Google Scholar
• VesseyMYeatesDFlynnSFactors affecting mortality in a large cohort study with special reference to oral contraceptive useContraception201082322122920705149
   PubMed Web of Science ®Google Scholar
• EndrikatJParkeSTrummerDSchmidtWDuijkersIKlippingCOvulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studiesContraception200878321822518692612
   PubMed Web of Science ®Google Scholar
• ÅgrenUMAnttilaMMäenpää-LiukkoKEffects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine functionEur J Contracept Reprod Health Care201116645846721942708
   PubMed Web of Science ®Google Scholar
• PalaciosSWildtLParkeSMachlittARömerTBitzerJEfficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trialEur J Obstet Gynecol Reprod Biol20101491576219969409
   PubMed Web of Science ®Google Scholar
• NelsonAParkeSMellingerUZampaglioneESchmidtAEfficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North AmericaJ Womens Health (Larchmt)201423320421024279594
   PubMed Web of Science ®Google Scholar
• FraserISRömerTParkeSEffective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trialHum Reprod201126102698270821784734
   PubMed Web of Science ®Google Scholar
• JensenJTParkeSMellingerUMachlittAFraserISEffective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trialObstet Gynecol2011117477778721422847
   PubMed Web of Science ®Google Scholar
• JensenJTParkeSMellingerUSerraniMMabeyRGHormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimateEur J Contracept Reprod Health Care201318427428323638631
   PubMed Web of Science ®Google Scholar
• WasiakRFilonenkoAVannessDJImpact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleedingJ Womens Health (Larchmt)201322437838423586801
   PubMed Web of Science ®Google Scholar
• RapsMRosendaalFBallieuxBResistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trialJ Thromb Haemost201311585586123410231
   PubMed Web of Science ®Google Scholar
• EndrikatJParkeSTrummerDSerraniMDuijkersIKlippingCPituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label studyContraception201387222723422995539
   PubMed Web of Science ®Google Scholar
• BlodeHZeunSParkeSEvaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal womenContraception201286433734422445438
   PubMed Web of Science ®Google Scholar
• CicinelliEPintoVQuattrominiPEndometrial preparation with estradiol plus dienogest (Qlaira) for office hysteroscopic polypectomy: randomized pilot studyJ Minim Invasive Gynecol201219335635922322156
   PubMed Web of Science ®Google Scholar
• FraserISJensenJSchaefersMMellingerUParkeSSerraniMNormalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogestContraception20128629610122240178
   PubMed Web of Science ®Google Scholar
• CarusoSAgnelloCRomanoMPreliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual lifeJ Sex Med20118102841285021810188
   PubMed Web of Science ®Google Scholar
• JungeWMellingerUParkeSSerraniMMetabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre studyClin Drug Investig2011318573584
   PubMed Web of Science ®Google Scholar
• KlippingCDuijkersIParkeSMellingerUSerraniMJungeWHemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrelDrugs R D201111215917021679006
   PubMedGoogle Scholar
• ZeunSLuMUddinAZeilerBMorrisonDBlodeHPharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogestEur J Contracept Reprod Health Care200914322123219565420
   PubMed Web of Science ®Google Scholar
• AhrendtHJMakalováDParkeSMellingerUMansourDBleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrelContraception200980543644419835717
   PubMed Web of Science ®Google Scholar
• PetragliaFParkeSSerraniMMellingerURömerTEstradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrheaInt J Gynaecol Obstet2014125327027424713413
   PubMed Web of Science ®Google Scholar
• Di CarloCGarganoVSpariceSTommaselliGABifulcoGNappiCEffects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary studyGynecol Endocrinol201329121048105024020909
   PubMed Web of Science ®Google Scholar
• MacìasGMerki-FeldGSParkeSMellingerUSerraniMEffects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II studyJ Obstet Gynaecol201333659159623919857
   PubMedGoogle Scholar
• WasiakRFilonenkoAVannessDJImpact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleedingInt J Womens Health2012427127822927764
   PubMedGoogle Scholar
• NappiRETerrenoESancesGEffect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM)Contraception201388336937523453784
   PubMed Web of Science ®Google Scholar
• DavisSRBitzerJGiraldiAChange to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunctionJ Sex Med201310123069307924034466
   PubMed Web of Science ®Google Scholar
• NelsonAParkeSMakalovaDSerraniMPalaciosSMellingerUEfficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and EuropeEur J Contracept Reprod Health Care201318426427323651474
   PubMed Web of Science ®Google Scholar
• FraserISParkeSMellingerUMachlittASerraniMJensenJEffective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogestEur J Contracept Reprod Health Care201116425826921774563
   PubMed Web of Science ®Google Scholar
• BifulcoGDi Spiezio SardoADe RosaNThe use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility studyGynecol Endocrinol2012281294995522571602
   PubMed Web of Science ®Google Scholar
• De LeoVFruzzettiFMusacchioMCScolaroVDi SabatinoAMorganteGEffect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolismContraception201388336436823769016
   PubMed Web of Science ®Google Scholar
• BitzerJParkeSRoemerTSerraniMEndometrial safety of an oral contraceptive containing estradiol valerate and dienogestInt J Womens Health2011312713221573149
   PubMedGoogle Scholar
• Di CarloCGarganoVSpariceSShort-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary studyEur J Contracept Reprod Health Care201318538839323859010
   PubMed Web of Science ®Google Scholar
• MueckAOSeegerHBühlingKJWhy use of dienogest for the first contraceptive pill with estradiol?Gynecol Endocrinol201026210911319672744
   PubMed Web of Science ®Google Scholar
• MueckAODinogest: an oral progestogen for the treatment of endometriosisExpert Rev Obstet Gynecol201161515
   Google Scholar
• LefebvreGPinsonneaultOAntaoVSOGCPrimary dysmenorrhea consensus guidelineJ Obstet Gynaecol Can200527121117114616524531
   PubMedGoogle Scholar
• HallbergLHögdahlAMNilssonLRyboGMenstrual blood loss – a population study. Variation at different ages and attempts to define normalityActa Obstet Gynecol Scand19664533203515922481
   PubMed Web of Science ®Google Scholar
• MunroMGCritchleyHOBroderMSFraserISFIGO Working Group on Menstrual DisordersFIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive ageInt J Gynaecol Obstet2011113131321345435
   PubMed Web of Science ®Google Scholar
• HallbergLNilssonLDetermination of menstrual blood lossScand J Clin Lab Invest19641624424814161862
   PubMed Web of Science ®Google Scholar
• KaunitzAMBissonnetteFMonteiroILukkari-LaxEMuysersCJensenJTLevonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trialObstet Gynecol2010116362563220733445
   PubMed Web of Science ®Google Scholar
• AnderssonJKRyboGLevonorgestrel-releasing intrauterine device in the treatment of menorrhagiaBr J Obstet Gynaecol19909786906942119218
   PubMedGoogle Scholar
• ReidPCVirtanen-KariSRandomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment chartsBJOG200511281121112516045528
   PubMed Web of Science ®Google Scholar
• TangGWLoSSLevonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptabilityContraception19955142312357796588
   PubMed Web of Science ®Google Scholar
• SulakPJScowRDPreeceCRiggsMWKuehlTJHormone withdrawal symptoms in oral contraceptive usersObstet Gynecol200095226126610674591
   PubMed Web of Science ®Google Scholar
• SulakPWillisSKuehlTCoffeeAClarkJHeadaches and oral contraceptives: impact of eliminating the standard 7-day placebo intervalHeadache2007471273717355491
   PubMed Web of Science ®Google Scholar
• BitzerJHormone withdrawal-associated symptoms: overlooked and under-exploredGynecol Endocrinol201329653053523421366
   PubMed Web of Science ®Google Scholar
• World Health OrganizationMedical Eligibility Criteria for Contraceptive Use4th edGenevaWorld Health Organization2010 Available from: http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdfAccessed January 22, 2014
   Google Scholar
• Centers for Disease Control and PreventionUS medical eligibility criteria for contraceptive use 2010MMWR201059186
   PubMedGoogle Scholar
• EdlowAGBartzDHormonal contraceptive options for women with headache: a review of the evidenceRev Obstet Gynecol201032556520842283
   PubMedGoogle Scholar
• Sitruk-WareRNew progestagens for contraceptive useHum Reprod Update200612216917816291771
   PubMed Web of Science ®Google Scholar
• MilsomIAnderssonKAnderschBRyboGA comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagiaAm J Obstet Gynecol199116438798831900665
   PubMed Web of Science ®Google Scholar
• XiaoBWuSCChongJZengTHanLHLuukkainenTTherapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagiaFertil Steril200379496396912749438
   PubMed Web of Science ®Google Scholar
• ShaabanMMShabaanMMZakherahMSEl-NasharSASayedGHLevonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trialContraception2011831485421134503
   PubMed Web of Science ®Google Scholar
• LukesASMooreKAMuseKNTranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trialObstet Gynecol2010116486587520859150
   PubMed Web of Science ®Google Scholar
• Center for Drug Evaluation and ResearchApplication number: 22-252, Original 1 Statistical Review(s)http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022252_Orig-1_StatR.pdfU.S. Department of Health and Human Services, Food and Drug Administration2010Accessed July 7, 2014
   Google Scholar